Respiratory News and Research

RSS

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

Pfizer Inc. announced today that the Japanese Ministry of Health, Labor and Welfare has approved XELJANZ (tofacitinib citrate) for the treatment of adults with rheumatoid arthritis who have had an inadequate response to existing therapies.

25 Mar 2013

Women, girls around the world at risk from inefficient cookstoves

"For mothers around the world, preparing the family meal is a daily ritual and an act of love. But it's also a grave risk for approximately three billion people who cook with open fires and inefficient stoves that burn solid fuels such as wood, animal and agricultural waste, and coal," Kathy Calvin, CEO of the United Nations Foundation, writes in the Huffington Post's "Global Motherhood" blog.

25 Mar 2013

$Commencing surgery sooner may alleviate hip fracture complications$

Commencing surgery sooner may alleviate hip fracture complications

A new study, presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons, identifies predictors of complications and mortality following a hip fracture, including dialysis, cardiac disease, diabetes, and a longer time before surgery - the only modifiable risk factor when patients are hospitalized.

22 Mar 2013

MU researchers redefine key regulatory process in defective protein responsible for cystic fibrosis

A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of Missouri researchers believe they have found exactly how this drug works and how to improve its effectiveness in the future.

22 Mar 2013

Trained Spanish nurses provide quality care comparable to that of general practitioners, study finds

A new study has found that Spanish nurses trained specifically to resolve acute health problems of low complexity provide care of comparable quality to that of general practitioners. Published early online in the Journal of Advanced Nursing, the findings suggest that nurses may be able to take on some of the care generally provided by physicians.

21 Mar 2013

DART Therapeutics develops new class of therapy for Duchenne muscular dystrophy

DART Therapeutics Inc., an innovative, new-model biotechnology firm focused on developing therapies for Duchenne muscular dystrophy, announced today that it is developing a SARM drug candidate obtained from Belgium-based Galapagos NV.

21 Mar 2013

Study examines overuse of ER for nonemergency visits

Visits to the ER are not always for true medical emergencies - and some policymakers have been fighting the problem by denying or limiting payments if the patient's diagnosis upon discharge is for "nonemergency" conditions.

21 Mar 2013

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

The Coalition for Pulmonary Fibrosis, the Pulmonary Fibrosis Foundation, and the American Thoracic Society-the world's leading professional organization for pulmonary, critical care and sleep medicine-today announced that the CPF and the PFF will again partner with the ATS to fund pulmonary fibrosis research.

21 Mar 2013

Research findings could lead to new treatments for lung disorders in premature babies

Researchers at Yale School of Medicine have made major discoveries that could lead to new treatments for lung disorders in premature babies. In a mouse study, the team located key molecules that switch on stress pathways in preterm lung disorders, and also found that when parts of these pathways were blocked with a pain drug, lung damage was prevented or reversed.

21 Mar 2013

EuroPRevent 2013 to explore low-cost solutions to global epidemic of cardiovascular diseases

Preventive cardiology is now on the political as well as clinical agenda. In 2011 a UN heads-of-state meeting agreed to reduce mortality from chronic non-communicable diseases by 25% by 2025.

21 Mar 2013

University of Pittsburgh researchers receive NIH grant to develop wearable artificial lung

Each year, nearly 350,000 Americans die of some form of lung disease, with another 150,000 patients needing short- and long-term care. Unfortunately, current breathing-support technologies are cumbersome, often requiring patients to be bedridden and sedated.

20 Mar 2013

Report: Nurses, midwives can play major role in improving health outcomes

Nurses and midwives can play a critical role in lessening people's risk of cardiovascular diseases, cancers, chronic respiratory disease and diabetes, according to a groundbreaking new report issued by the World Health Organization and co-authored by a UCLA nursing professor.

20 Mar 2013

Genetic testing services for rare neurological disorders launched by Athena Diagnostics

Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world’s leading provider of diagnostic information services.

From Quest Diagnostics 19 Mar 2013

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

19 Mar 2013

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013, in San Diego.

18 Mar 2013

Breathing disorder tests for Down syndrome children to be investigated by researchers at the University of Southampton

Researchers at the University of Southampton are planning to investigate tests for a breathing disorder that affects babies and children who have Down syndrome while they sleep. They aim to provide the missing evidence so that doctors can introduce affordable and simple routine screening.

15 Mar 2013

Diffusion Pharmaceuticals enrolls patients with primary brain cancer in Phase II clinical trial of TSC

Diffusion Pharmaceuticals LLC today announced completion of enrollment in a Phase II clinical trial of trans sodium crocetinate, its lead compound for the treatment of cancer.

15 Mar 2013

Previously unknown cell discovered in the urethra of mice

A recent study conducted by a group of German scientists revealed the presence of a previously unknown cell in the urethra of mice. These chemosensory cholinergic brush cells are in close contact to sensory neurons that express cholinergic receptors.

15 Mar 2013

Researchers identify enzymes that activate coronavirus for infection

Scientists all over the world are on a quest for an antidote since the first patient died from the new coronavirus in summer 2012. Infection Researchers from the German Primate Center have now identified enzymes that activate the virus for infection.

15 Mar 2013

New research technique now available in Journal of Visualized Experiments

A new research technique, pioneered by Dr. Maria Angela Franceschini, will be published in JoVE (Journal of Visualized Experiments) on March 14th. Researchers at Massachusetts General Hospital and Harvard Medical School have developed a non-invasive optical measurement system to monitor neonatal brain activity via cerebral metabolism and blood flow.

15 Mar 2013

Respiratory News and Research

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

Women, girls around the world at risk from inefficient cookstoves

Commencing surgery sooner may alleviate hip fracture complications

MU researchers redefine key regulatory process in defective protein responsible for cystic fibrosis

Trained Spanish nurses provide quality care comparable to that of general practitioners, study finds

DART Therapeutics develops new class of therapy for Duchenne muscular dystrophy

Study examines overuse of ER for nonemergency visits

CPF and PFF to partner with ATS to fund pulmonary fibrosis research

Research findings could lead to new treatments for lung disorders in premature babies

EuroPRevent 2013 to explore low-cost solutions to global epidemic of cardiovascular diseases

University of Pittsburgh researchers receive NIH grant to develop wearable artificial lung

Report: Nurses, midwives can play major role in improving health outcomes

Genetic testing services for rare neurological disorders launched by Athena Diagnostics

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Breathing disorder tests for Down syndrome children to be investigated by researchers at the University of Southampton

Diffusion Pharmaceuticals enrolls patients with primary brain cancer in Phase II clinical trial of TSC

Previously unknown cell discovered in the urethra of mice

Researchers identify enzymes that activate coronavirus for infection

New research technique now available in Journal of Visualized Experiments

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News